{
    "clinical_study": {
        "@rank": "90628", 
        "acronym": "AML", 
        "arm_group": {
            "arm_group_label": "1"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is evaluate patients with acute myeloid leukemia (<=66 years),\n      treated with conventional and experimental chemotherapy following allogeneic\n      transplantation. THis patients have been enrolled from 2000 to 2011 at the Division of\n      Hematology, Molinette University Hospital. The purpose of data collection is to assess, with\n      retrospective analysis, the clinical outcome divided by risk class and evaluated in patients\n      who achieve complete remission after induction therapy and consolidation."
        }, 
        "brief_title": "Conventional and Experimental Chemotherapy With Allogeneic Transplant in Young Patients With Acute Myeloid Leukaemia", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Myeloid Leukemia", 
        "condition_browse": {
            "mesh_term": [
                "Leukemia", 
                "Leukemia, Myeloid, Acute", 
                "Leukemia, Myeloid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Patients with acute myeloid leukemia (<=66 years), treated with conventional and\n        experimental chemotherapy following allogeneic transplantation. THis patients have been\n        enrolled from 2000 to 2011 at the Division of Hematology, Molinette University Hospital."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "66 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Acute myeloid leukemia patients"
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01785953", 
            "org_study_id": "AML-TO-2012"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 6, 2013", 
        "location": {
            "contact": {
                "email": "benedetto.bruno@unito.it", 
                "last_name": "Benedetto Bruno, MD", 
                "phone": "+390116336728"
            }, 
            "facility": {
                "address": {
                    "city": "Torino", 
                    "country": "Italy", 
                    "zip": "10126"
                }, 
                "name": "Citt\u00e0 della Salute e della Scienza di Torino"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "1", 
        "official_title": "CONVENTIONAL AND EXPERIMENTAL CHEMOTHERAPY WITH ALLOGENEIC TRANSPLANT IN YOUNG PATIENTS WITH ACUTE MYELOID LEUKAEMIA", 
        "overall_contact": {
            "email": "benedetto.bruno@unito.it", 
            "last_name": "Benedetto Bruno, MD", 
            "phone": "+390116336728"
        }, 
        "overall_contact_backup": {
            "email": "gismm2001@yahoo.com", 
            "last_name": "Benedetto Bruno, MD", 
            "phone": "+390116336728"
        }, 
        "overall_official": {
            "affiliation": "Divisione di Ematologia-Citt\u00e0 della Salute e della Scienza di Torino", 
            "last_name": "Benedetto Bruno, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Overall survival", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Event-free survival", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01785953"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Azienda Ospedaliera San Giovanni Battista", 
            "investigator_full_name": "Benedetto Bruno", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Azienda Ospedaliera San Giovanni Battista", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Azienda Ospedaliera San Giovanni Battista", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "February 2013"
    }
}